NFKB1 and Stroke: Previous in vitro studies modeling traumatic brain injury, cerebral ischemia/reperfusion injury, and stroke have confirmed the presence of anti-inflammatory effects driven by suppressed activation of the NF-kB and p38MAPK pathways [112,113,114].